DEVELOPMENT OF A MEDICINAL AGENT BASED ON THE PEPTIDE ANTAGONIST OF OREXIN RECEPTOR FOR SUPPRESSION OF ALCOHOL DEPENDENCE



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The aims of the research were to synthesize gene, coding previously designed artificial protein antorex - the antagonist of orexins receptor OxR1, to explore it's expression in Escherichia coli cells and to develop the process of this protein purification from Escherichia coli cell lysates. Methods of chemical and enzymatic DNA synthesis, genetic engineering, selection and chromatography were used. The gene coding antorex protein was synthesized, the plasmid DNA рЕТ-antorex, containing this gene and Escherichia coli strain BL21(pЕT-аntorex) - the stable producer of recombinant protein antorex were obtained. Methods of Escherichia coli producer strain cultivation and antorex protein purification with the use of reverse-phase and ion-exchange chromatography was developed. Large-scale cultivation of producer strain was performed in 10L fermenter and the pilot lot of 480 mg of antorex protein with the purity of 97,5% was produced. The developed methods lead to production and purification of antorex artificial protein for conducting pre-clinical and clinical trials.

Full Text

Restricted Access

About the authors

I V Duhovlinov

Institute of Experimental Medicine

N A Klimov

Institute of Experimental Medicine

E A Fedorova

Institute of Experimental Medicine

Yu V Zherebcova

Institute of Experimental Medicine

E A Chernyaeva

Institute of Experimental Medicine

A I Orlov

Institute of Experimental Medicine

References

  1. Sakurai Т. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology // Regulatory peptides. 2005. Vol. 126, No 1. Р. 3-10.
  2. DiLeone R.J., Georgescu D., Nestler E.J. Lateral hypothalamic neuropeptides in reward and drug addiction // Life Sci. 2003. Vol. 73, No 6. P. 759-768.
  3. Paneda C., Winsky-Sommerer R., Boutrel B., de Lecea L. The corticotropin-releasing factor hypocretin connection: implications in stress response and addiction // Drug News Perspect. 2005. Vol. 18, No 4. P. 250-255.
  4. Harris G.C., Wimmer M., Aston J.G. A role for lateral hypothalamic orexin neurons in reward seeking // Nature. 2005. Vol. 437, No 7058. P. 556-559.
  5. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine // Neuron. 2006. Vol. 49, No 4. P. 589-601.
  6. Pasumarthi R.K., Reznikov L.R., Fadel J. Activation of orexin neurons by acute nicotine // Eur. J. Pharmacol. 2006. Vol. 535, No 1-3. P. 172-176.
  7. Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., Sakurai T., Yanagisawa M., Nakamachi T., Shioda S., Suzuki T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine // J. of Neurosci. 2006. Vol. 26, No 2. P. 398-405.
  8. Majumder K. Ligation-free gene synthesis by PCR: synthesis and mutagenesis at multiple loci of a chimeric gene encoding OmpA signal peptide and hirudin // Gene. 1992. Vol. 110, No 1. P. 89-94.
  9. Laemmly U.K. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 // Nature. 1970. Vol. 227. P. 680-685.
  10. Studier F.W. Stable expression clones and auto-induction for protein production in E. coli // Methods Mol Biol. 2014. Vol. 1091, No 1. P. 17-32.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Duhovlinov I.V., Klimov N.A., Fedorova E.A., Zherebcova Y.V., Chernyaeva E.A., Orlov A.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies